These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1695989)

  • 1. A putative approach for gene therapy against human immunodeficiency virus (HIV).
    Faraji-Shadan F; Stubbs JD; Bowman PD
    Med Hypotheses; 1990 Jun; 32(2):81-4. PubMed ID: 1695989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus and the hematopoietic repertoire: implications for gene therapy.
    Panoskaltsis N; Abboud CN
    Front Biosci; 1999 May; 4():D457-67. PubMed ID: 10228094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.
    Maciejewski JP; Weichold FF; Young NS; Cara A; Zella D; Reitz MS; Gallo RC
    Nat Med; 1995 Jul; 1(7):667-73. PubMed ID: 7585149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals.
    Gervaix A; Schwarz L; Law P; Ho AD; Looney D; Lane T; Wong-Staal F
    Hum Gene Ther; 1997 Dec; 8(18):2229-38. PubMed ID: 9449376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
    Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
    Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting HIV reverse transcriptase in novel ways.
    Wainberg MA; Gu Z
    Nat Med; 1995 Jul; 1(7):628-9. PubMed ID: 7585138
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
    Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP
    Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular immunization or immunotherapy for HIV infection?
    Featherstone C
    Mol Med Today; 1996 Jul; 2(7):271. PubMed ID: 8796904
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.
    Lo HL; Chang T; Yam P; Marcovecchio PM; Li S; Zaia JA; Yee JK
    Gene Ther; 2007 Nov; 14(21):1503-12. PubMed ID: 17805304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic-stem-cell-based gene therapy for HIV disease.
    Kiem HP; Jerome KR; Deeks SG; McCune JM
    Cell Stem Cell; 2012 Feb; 10(2):137-47. PubMed ID: 22305563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.
    McArthur CP; Wang Y; Heruth D; Gustafson S
    Arch Oral Biol; 2001 Jun; 46(6):545-55. PubMed ID: 11311202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.
    Garg H; Joshi A
    Hum Gene Ther; 2016 May; 27(5):400-15. PubMed ID: 26800572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
    Duan L; Zhu M; Bagasra O; Pomerantz RJ
    Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus.
    Sano K; Lee MH; Morales F; Nishanian P; Fahey J; Detels R; Imagawa DT
    J Clin Microbiol; 1987 Dec; 25(12):2415-7. PubMed ID: 2448336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
    Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
    Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
    Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
    Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.